LY341495 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets mGluR1a, mGluR2, mGluR3, mGluR4, mGluR5a, mGluR7, and mGluR8.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
